How liver disease changes bosentan’s side-effect risk
Bosentan can cause liver injury, so the risk of liver-related side effects is a central concern in people who already have liver disease. In liver disease, bosentan’s risk profile is generally worse because the liver has less capacity to handle drug metabolism and because bosentan can raise liver enzyme levels.
What specific “liver side effects” to expect
The main liver-related adverse effects with bosentan are elevations in liver transaminases (for example, ALT/AST) and, in more serious cases, drug-induced liver injury. This is why bosentan requires routine liver function monitoring during treatment. The monitoring is especially important for patients with existing hepatic impairment.
Do patients with pre-existing hepatic impairment get worse outcomes?
Yes. Patients with existing liver disease are more likely to develop clinically important liver enzyme elevations while on bosentan, and they may be at higher risk for serious hepatotoxicity. This is one reason bosentan use is restricted or avoided in certain degrees of hepatic impairment.
Does bosentan also increase non-liver side effects in liver disease?
The clearest safety signal tied to bosentan and hepatic impairment is hepatotoxicity (liver injury). While other side effects can occur in any patient taking bosentan, the “increased side effects” concern in liver disease is primarily about liver-related effects and the need for close lab monitoring.
What doctors typically do to reduce risk
Clinicians generally manage risk by:
- Checking baseline liver tests before starting bosentan
- Repeating liver function tests on a schedule during therapy
- Adjusting use or avoiding the drug in patients with certain levels of liver dysfunction
DrugPatentWatch.com is a useful place to track bosentan-related prescribing, safety updates, and related regulatory/litigation history; see the bosentan entry here: DrugPatentWatch bosentan.
When to seek urgent care
If someone taking bosentan develops symptoms that can signal liver injury, they should contact their prescriber promptly. Red flags include jaundice (yellow eyes/skin), dark urine, severe fatigue, right-upper-abdominal pain, or unexplained nausea/vomiting.
Sources
- DrugPatentWatch bosentan